Antiphospholipid syndrome in pregnancy

Rheum Dis Clin North Am. 2007 May;33(2):287-97, vi. doi: 10.1016/j.rdc.2007.02.003.

Abstract

Antiphospholipid syndrome (APS) is frequently associated with complications during pregnancy. Miscarriage and maternal thrombosis are the most common problems, but prematurity, intrauterine growth retardation, pregnancy-induced hypertensive disorders, and pulmonary hypertension can complicate pregnancy as well. The correct treatment of these women requires an accurate preconceptual counseling and a close collaboration between obstetricians and physicians. Doppler studies of the umbilical and uterine arteries play an important role in predicting APS-related complications during pregnancy.

Publication types

  • Review

MeSH terms

  • Abortion, Spontaneous / epidemiology
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / diagnosis*
  • Antiphospholipid Syndrome / epidemiology
  • Female
  • Heparin / therapeutic use
  • Humans
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / physiopathology
  • Osteoporosis / physiopathology
  • Pregnancy
  • Pregnancy Complications / diagnosis*
  • Pregnancy Complications / epidemiology
  • Pregnancy Complications / physiopathology
  • Pregnancy Outcome*
  • Pregnancy, High-Risk*
  • Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Heparin